HORMAD1 and breast carcinoma: To assess HORMAD1 expression in breast cancer subtypes, we analyzed RNAseq data for breast cancer from The Cancer Genome Atlas (TCGA) and associated HORMAD1 expression with receptor status, clinicopathological subtypes, and Prediction Analysis of Microarray 50 (PAM50) groups (Figure 1B, Supplementary Figure 1A).